{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:25:44Z","timestamp":1786987544720,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.critrevonc.2025.104836","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T20:39:04Z","timestamp":1751661544000},"page":"104836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The role of HER2 pathway in vulvar paget\u2019s disease"],"prefix":"10.1016","volume":"214","author":[{"given":"Giulia","family":"Pomati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8319-6146","authenticated-orcid":false,"given":"Giacomo","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Palluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Maria","family":"Fragomeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Lanzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Garganese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.critrevonc.2025.104836_bib1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3390\/diagnostics10121040","article-title":"Hormonal environment and HER2 status in extra-mammary Paget's Disease (eMPD): a systematic literature review and meta-analysis with clinical considerations","volume":"10","author":"Angelico","year":"2020","journal-title":"Diagnostics"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104836_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jdermsci.2007.12.002","article-title":"High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease","volume":"50","author":"Aoyagi","year":"2008","journal-title":"J. Dermatol. Sci."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104836_bib3","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1136\/ijgc-2020-001771","article-title":"Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva","volume":"30","author":"Bartoletti","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104836_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.pdm.0000213456.30151.5b","article-title":"HER-2 gene amplification in Paget disease of the nipple and extramammary site: a chromogenic in situ hybridization study","volume":"15","author":"Bianco","year":"2006","journal-title":"Diagn. Mol. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104836_bib5","first-page":"471","article-title":"Pseudoinvasive, nodular extramammary Paget's disease of the vulva","volume":"122","author":"Billings","year":"1998","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.critrevonc.2025.104836_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1158\/2159-8290.CD-12-0349","article-title":"Activating HER2 mutations in HER2 gene amplification negative breast cancer","volume":"3","author":"Bose","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2025.104836_bib7","article-title":"Treatment of invasive Paget's disease of the vulva in pregnancy: a case report","volume":"33","author":"Bruce","year":"2020","journal-title":"Gynecol. Oncol. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104836_bib8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2004.07.043","article-title":"HER-2\/neu expression in Paget disease of the vulva and the female breast","volume":"95","author":"Brummer","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104836_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1600-0560.2001.280208.x","article-title":"Depigmented genital extramammary Paget\u2019s disease: a possible histogenetic link to Toker\u2019s clear cells and clear cell papulosis","volume":"28","author":"Chen","year":"2001","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104836_bib10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature01392","article-title":"Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab","volume":"421","author":"Cho","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2025.104836_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00004347-199910000-00010","article-title":"Prognostic factors in Paget\u2019s disease of the vulva: a study of 21 cases","volume":"18","author":"Crawford","year":"1999","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104836_bib12","series-title":"WHO Classification of Tumours of Female Reproductive Organs. Fourth ed.","first-page":"236","article-title":"Tumours of the vulva","author":"Crum","year":"2014"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104836_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00404-024-07418-0","article-title":"Metastatic Extramammary Paget's Disease with near-complete response to trastuzumab and paclitaxel therapy","volume":"310","author":"Dao","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1 Pt 1","key":"10.1016\/j.critrevonc.2025.104836_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0002-9378(99)70143-2","article-title":"Paget\u2019s disease of the vulva: Prevalence of associated vulvar adenocarcinoma, invasive Paget\u2019s disease, and recurrence after surgical excision","volume":"180","author":"Fanning","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.critrevonc.2025.104836_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.biophys.37.032807.125829","article-title":"Structure-based view of epidermal growth factor receptor regulation","volume":"37","author":"Ferguson","year":"2008","journal-title":"Annu Rev. Biophys."},{"key":"10.1016\/j.critrevonc.2025.104836_bib16","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104836_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00404-022-06408-4","article-title":"\"Clock mapping\" prior to excisional surgery in vulvar Paget's disease: tailoring the surgical plan","volume":"306","author":"Garganese","year":"2022","journal-title":"Arch. Gynecol. Obstet."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104836_bib18","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00432-019-02975-3","article-title":"The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar Paget's disease","volume":"145","author":"Garganese","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104836_bib19","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/cam4.2820","article-title":"Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease","volume":"9","author":"Gatalica","year":"2020","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104836_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000333002","article-title":"A case of metastatic extramammary Paget's disease responding to Trastuzumab plus Paclitaxel Combination Therapy","volume":"3","author":"Hanawa","year":"2011","journal-title":"Case Rep. Dermatol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104836_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/1066896912444159","article-title":"Immunohistochemical and fluorescence in situ hybridization studies on noninvasive and invasive extramammary Paget's disease","volume":"20","author":"Hikita","year":"2012","journal-title":"Int. J. Surg. Pathol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104836_bib22","doi-asserted-by":"crossref","first-page":"e1201","DOI":"10.1093\/oncolo\/oyae097","article-title":"Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC)","volume":"29","author":"Hirai","year":"2024","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104836_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00404-007-0434-1","article-title":"COX-2 and Her-2\/neu are overexpressed in Paget's disease of the vulva and the breast: results of a preliminary study","volume":"277","author":"Horn","year":"2008","journal-title":"Arch. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104836_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00204","article-title":"Case of metastatic extramammary paget disease of the vulva treated successfully with Trastuzumab Emtansine","author":"Hsieh","year":"2018","journal-title":"JCO Precis. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104836_bib25","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41416-024-02788-3","article-title":"Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism","volume":"131","author":"Hsu","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104836_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3892\/mco.2017.1422","article-title":"Successful and long-term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2-positive extramammary Paget's disease: a case report and review of the literature","volume":"7","author":"Ichiyama","year":"2017","journal-title":"Mol. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104836_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.annder.2020.08.048","article-title":"Complete but transient clinical remission of vulvar Paget's disease with paclitaxel and trastuzumab","volume":"148","author":"Isnard","year":"2021","journal-title":"Ann. Dermatol. Venereol."},{"key":"10.1016\/j.critrevonc.2025.104836_bib28","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1470-2045(21)00336-3","article-title":"Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study","volume":"22","author":"Javle","year":"2021","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104836_bib29","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2007.12.014","article-title":"HER-2\/neu targeting for recurrent vulvar Paget's disease A case report and literature review","volume":"111","author":"Karam","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104836_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa2112431","article-title":"DESTINY-Lung01 trial investigators. Trastuzumab Deruxtecan in HER2-mutant non-small-cell lung cancer","volume":"386","author":"Li","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2025.104836_bib31","first-page":"1283","article-title":"Androgen receptors are frequently expressed in mammary and extramammary Paget\u2019s disease","volume":"18","author":"Liegl","year":"2005","journal-title":"Mod. Pathol. J. U S Can. Acad. Pathol. Inc."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104836_bib32","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1600-0560.2009.01403.x","article-title":"Mammary Paget's disease and extra-mammary Paget's disease: two morphologically similar but biologically different diseases","volume":"37","author":"Liu","year":"2010","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104836_bib33","series-title":"Int J Gynecol Cancer","article-title":"Reviewing vulvar Paget's disease molecular bases. Looking forward to personalized target therapies: a matter of CHANGE","author":"Mantovani","year":"2019"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104836_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5582\/bst.2011.v5.4.151","article-title":"The expression of HER-2 in extramammary Paget's disease","volume":"5","author":"Masuguchi","year":"2011","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.critrevonc.2025.104836_bib35","doi-asserted-by":"crossref","first-page":"114371","DOI":"10.18632\/oncotarget.22825","article-title":"Genomic alterations of ERBB receptors in cancer: clinical implications","volume":"8","author":"Mishra","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104836_bib36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/his.13086","article-title":"GATA3 expression in primary vulvar Paget disease: a potential pitfall leading to misdiagnosis of pagetoid urothelial intraepithelial neoplasia","volume":"70","author":"Morbeck","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2025.104836_bib37","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.bmcl.2016.02.020","article-title":"Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads","volume":"26","author":"Nakada","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"62","key":"10.1016\/j.critrevonc.2025.104836_bib38","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.18632\/oncotarget.27272","article-title":"Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2S310F mutated extramammary Paget's disease","volume":"10","author":"Nordmann","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.104836_bib39","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.humpath.2005.09.009","article-title":"Extramammary Paget\u2019s disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein","volume":"36","author":"Ogawa","year":"2005","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104836_bib40","first-page":"10","article-title":"Primary extramammary invasive Paget\u2019s vulvar disease: what is the standard, what are the challenges and what is the future for radiotherapy?","volume":"16","author":"olia","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2025.104836_bib41","series-title":"Current Oncology Reports","first-page":"1081","article-title":"Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity","author":"P\u00e9rez","year":"2023"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104836_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/DAD.0b013e3181b71481","article-title":"The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease","volume":"32","author":"Perrotto","year":"2010","journal-title":"Am. J. Derm."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104836_bib43","first-page":"170","article-title":"Sweat gland carcinoma with bone and visceral metastases. Prolonged complete remission lasting 16 months as a result of chemotherapy","volume":"60","author":"Piedbois","year":"1987","journal-title":"Int. Interdiscip. J. Am. Cancer Soc."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104836_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1600-0560.2008.01148.x","article-title":"HER-2\/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy","volume":"36","author":"Plaza","year":"2009","journal-title":"J. Cutan. Pathol."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104836_bib45","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-22-0283","article-title":"Molecular pathways and mechanisms of HER2 in Cancer therapy","volume":"29","author":"Raghav","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104836_bib46","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/modpathol.3800243","article-title":"p185HER2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget's disease","volume":"18","author":"Reich","year":"2005","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104836_bib47","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jcp.2010.077446","article-title":"HER-2\/NEU overexpression in vulvar Paget disease: the Yale experience","volume":"63","author":"Richter","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104836_bib48","unstructured":"Scheistr\u00f8en M., Trope C., Kaern J., et al. DAN ploidy and expression of p53 and CerbB-2 in extramammary Paget\u2019s disease of the vulva. Gynecol Oncol, 10.1136\/jcp.2010.077446."},{"key":"10.1016\/j.critrevonc.2025.104836_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/msb4100012","article-title":"Phosphotyrosine interactome of the ErbB-receptor kinase family","author":"Schulze","year":"2005","journal-title":"Mol. Syst. Biol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104836_bib50","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/1346-8138.15515","article-title":"Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget's disease: four cases and a review","volume":"47","author":"Sekiguchi","year":"2020","journal-title":"J. Dermatol."},{"key":"10.1016\/j.critrevonc.2025.104836_bib51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00918679","article-title":"Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic","volume":"11","author":"Shepard","year":"1991","journal-title":"J. Clin. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104836_bib52","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(21)00086-3","article-title":"DESTINY-CRC01 investigators. Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial","volume":"22","author":"Siena","year":"2021","journal-title":"Lancet Oncol."},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104836_bib53","doi-asserted-by":"crossref","first-page":"15159","DOI":"10.1002\/cam4.6190","article-title":"Treatment outcomes of advanced\/metastatic extramammary Paget's disease in Korean patients: KCSG-RC20-06","volume":"12","author":"Sohn","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.critrevonc.2025.104836_bib54","article-title":"Genomic alterations as potential therapeutic targets in extramammary Paget's Disease of the Vulva","volume":"4","author":"Stasenko","year":"2020","journal-title":"JCO Precis Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104836_bib55","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/IGC.0000000000001237","article-title":"The Role of Radiotherapy in Extramammary Paget Disease: a Systematic Review","volume":"28","author":"Tagliaferri","year":"2018","journal-title":"Int J. Gynecol. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104836_bib56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1200\/JCO.18.00545","article-title":"Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary Duct Carcinoma","volume":"37","author":"Takahashi","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104836_bib57","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/bjd.12249","article-title":"Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease","volume":"168","author":"Tanaka","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.critrevonc.2025.104836_bib58","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10585-016-9804-z","article-title":"Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease","volume":"33","author":"Tanaka","year":"2016","journal-title":"Clin. Exp. Metastas."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104836_bib59","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2559.2003.01648.x","article-title":"HER2 oncogene amplification in extramammary Paget's disease","volume":"42","author":"Tanskanen","year":"2003","journal-title":"Histopathology"},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104836_bib60","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.3390\/cancers14143519","article-title":"HER2-targeted antibody-drug conjugates display potent antitumor activities in preclinical extramammary Paget's Disease models: in vivo and immunohistochemical analyses","volume":"14","author":"Tokuchi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104836_bib61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.critrevonc.2016.03.008","article-title":"Paget disease of the vulva","volume":"101","author":"Van der Linden","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2025.104836_bib62","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"Von Minckwitz","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104836_bib63","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1634\/theoncologist.2014-0054","article-title":"Treatment of metastatic extramammary Paget's disease associated with adnexal adenocarcinoma, with anti-HER2 drugs based on genomic alteration ERBB2 S310F","volume":"19","author":"Vornicova","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2025.104836_bib64","article-title":"Dramatic clinical response of relapsed metastatic extramammary Paget's disease to trastuzumab monotherapy","volume":"2012","author":"Wakabayashi","year":"2012","journal-title":"Case Rep. Dermatol. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104836_bib65","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s10637-016-0329-8","article-title":"Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease","volume":"34","author":"Watanabe","year":"2016","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.critrevonc.2025.104836_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.925551","article-title":"Case Report: prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin","volume":"12","author":"Zattarin","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:13:29Z","timestamp":1758590009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825002240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":66,"alternative-id":["S1040842825002240"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104836","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of HER2 pathway in vulvar paget\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104836"}}